30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Hemrajani Rekha

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hemrajani Rekha's trades of MaxCyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-27 2025-06-25
US MaxCyte Inc (MXCT)
PlS Planned sale
31,293 +49.7%
113.57
US$4,636,079 		31,293 +49.7% 113.57 US$4,636,079
2025-06-25 2025-06-25
US MaxCyte Inc (MXCT)
PrS Proposed sale
55,725
337.80
US$532,901 		55,725 337.80 US$532,901
2024-12-04 2024-12-02
B Purchase
70,914 -35.5%
461.07
US$1,300,315 		70,914 -35.5% 461.07 US$1,300,315
2020-07-21 2020-07-21
B Purchase
3,000 +inf%
19.00
US$57,000 		3,000 +inf% 19.00 US$57,000